Xenetic Biosciences Inc Net Income per Employee (XBIO), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Xenetic Biosciences Inc   (NASDAQ: XBIO)
 

Xenetic Biosciences Inc Net Income per Employee

XBIO's Quarterly Results, Trends, Rankings, Statistics
Xenetic Biosciences Inc recorded a cumulative net loss of $-2 million during 12 month ending in the first quarter 2026.
The Healthcare sector has seen employees of 234 other companies achieving higher income per employee. While Xenetic Biosciences Inc 's total ranking has deteriorated compared to the previous quarter from 2529 to 3712.


What is Income per Employee Ratio?






XBIO Net Income per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,117,051 -1,340,430 -1,578,153 -1,541,518 -1,834,152
XBIO's Total Ranking # 3712 # 2529 # 2334 # 2606 # 3120
Seq. Net Income Change - - - - -


XBIO Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 235
Healthcare Sector # 613
Overall Market # 3712

Net Income per Employee Statistics
High Average Low
$ 357,583 $ -5,802,764 $ -30,146,941
(Dec 31 2021)   (Jun 30 2016)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026


Date modified: 2026-06-22T11:02:55+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.